Cencora, Inc. (COR)
NYSE: COR · Real-Time Price · USD
291.04
+1.89 (0.65%)
Aug 13, 2025, 4:00 PM - Market closed
Cencora Employees
Cencora had 46,000 employees as of September 30, 2024. The number of employees did not change compared to the previous year.
Employees
46,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$6,883,791
Profits / Employee
$41,245
Market Cap
56.43B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 46,000 | 0 | - |
Sep 30, 2023 | 46,000 | 2,000 | 4.55% |
Sep 30, 2022 | 44,000 | 2,000 | 4.76% |
Sep 30, 2021 | 42,000 | 20,000 | 90.91% |
Sep 30, 2020 | 22,000 | 0 | - |
Sep 30, 2019 | 22,000 | 1,000 | 4.76% |
Sep 30, 2018 | 21,000 | 1,000 | 5.00% |
Sep 30, 2017 | 20,000 | 1,000 | 5.26% |
Sep 30, 2016 | 19,000 | 1,500 | 8.57% |
Sep 30, 2015 | 17,500 | 3,500 | 25.00% |
Sep 30, 2014 | 14,000 | 1,000 | 7.69% |
Sep 30, 2013 | 13,000 | -1,500 | -10.34% |
Sep 30, 2012 | 14,500 | 4,200 | 40.78% |
Sep 30, 2011 | 10,300 | 300 | 3.00% |
Sep 30, 2010 | 10,000 | -300 | -2.91% |
Sep 30, 2009 | 10,300 | -600 | -5.50% |
Sep 30, 2008 | 10,900 | -400 | -3.54% |
Sep 30, 2007 | 11,300 | -3,400 | -23.13% |
Sep 30, 2006 | 14,700 | 1,300 | 9.70% |
Sep 30, 2005 | 13,400 | -700 | -4.96% |
Sep 30, 2004 | 14,100 | -700 | -4.73% |
Sep 30, 2003 | 14,800 | 1,100 | 8.03% |
Sep 30, 2002 | 13,700 | 0 | - |
Sep 30, 2001 | 13,700 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
COR News
- 1 day ago - Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap - Seeking Alpha
- 5 days ago - Cencora Q3: Growing Specialty Drug Distributions, Initiate At Buy - Seeking Alpha
- 7 days ago - Cencora, Inc. (COR) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Cencora raises annual profit forecast on strong demand for specialty drugs - Reuters
- 8 days ago - Cencora Reports Fiscal 2025 Third Quarter Results - Business Wire
- 6 weeks ago - Cencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings Release - Business Wire
- 2 months ago - Cencora Elects Lori J. Ryerkerk to Its Board of Directors - Business Wire
- 3 months ago - Cencora Continues To Deliver As A Healthcare Distributor With Further Growth Signs - Seeking Alpha